NIH-funded research Fellowship grant

Understanding how epigenetic changes affect germ cell development

Official title: Determining cis- and trans- regulatory mechanisms of epigenetic bivalency

Funded at Yale University · NIH-10914680 · Data updated 2026-11-12

This study is looking at how certain changes in our genes help germ cells, which are important for making babies, stay flexible enough to develop into different types of cells while still keeping their potential for growth.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startSeptember 30, 2022
Project endSeptember 29, 2025
Funding year2024
Award (this year)$33,892
NIH project number5F31HD107950-03
Project IDNIH-10914680 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals experiencing infertility or developmental issues related to germ cell function.

Less likely to help

Patients with conditions unrelated to germ cell biology or those not seeking fertility treatments may not benefit from this research.

What this research studies

This research investigates the complex mechanisms that regulate epigenetic bivalency in germ cells, which are crucial for the development of offspring. By utilizing advanced CRISPR techniques, the study aims to identify the molecular factors that maintain the balance between gene activation and repression in these cells. This understanding could provide insights into how germ cells retain their potential for development while also differentiating into specific cell types. The research focuses on the role of specific histone modifications that influence gene expression during early development.

Why it matters

Potential benefit: If successful, this research could lead to breakthroughs in reproductive health and developmental biology, potentially improving fertility treatments and understanding developmental disorders.

How similar studies have gone: Previous research has shown promising results in understanding epigenetic mechanisms using CRISPR technology, indicating that this approach has potential for success.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Marshall, Kira — Yale University
  • Study coordinator: Marshall, Kira

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.